Red Seaweed Pigment Emerges as Biomedical Breakthrough

In the vast and often under-explored world of marine biotechnology, a recent study has uncovered promising potential within a common red seaweed, Kappaphycus alvarezii, that could revolutionize the biomedical and pharmaceutical industries. Researchers, led by Harinathan Balasundaram from the Department of Microbiology at Krishna Institute of Science and Technology, have isolated and characterized a pigment called phycoerythrin from this seaweed, demonstrating its significant antimicrobial, antioxidant, and anticancer properties.

Kappaphycus alvarezii, widely cultivated for its carrageenan polysaccharide, has now been found to be a potential source of phycoerythrin, a pigment with substantial biomedical applications. “The protein content of phycoerythrin pigment extracted from K. alvarezii was found to be 69.84%, indicating its high purity and potential for various therapeutic uses,” Balasundaram explained. The study, published in the journal Scientific Reports (which translates to “Reports of Science” in English), revealed that this pigment exhibited excellent antimicrobial activity against harmful bacteria like Klebsiella oxytoca and Proteus mirabilis, with a minimum inhibition zone of 11 mm.

The research also highlighted the pigment’s significant in vitro antioxidant activity, as analyzed through various assays, including total antioxidant, hydrogen peroxide scavenging, reducing power, DPPH, and ABTS. Moreover, the pigment showed potent cytotoxicity against a human lung cancer cell line, with an IC50 value of 131.7 µg mL−1. “Increasing concentrations of phycoerythrin pigment decreased cell proliferation and induced apoptosis, as confirmed by Annexin V/PI staining,” Balasundaram noted. This finding underscores the pigment’s potential as a natural therapeutic agent in combating cancer.

Comprehensive characterization using FT-IR, HPLC, and GC-MS analysis revealed the nature of the pigment and its functional groups, further emphasizing its potential for biomedical applications. The molecular docking of K. alvarezii-derived compounds revealed significant binding affinities with 13 antibacterial target proteins, highlighting the seaweed’s bioactive compounds as promising antibacterial agents.

The implications of this research are far-reaching. As the world grapples with antibiotic resistance and the need for novel cancer treatments, the discovery of phycoerythrin’s multifaceted therapeutic properties offers a glimmer of hope. “These results highlight the potential of K. alvarezii bioactive compounds as promising antibacterial agents,” Balasundaram stated. The study’s findings support the seaweed’s potential application in the biomedical and pharmaceutical industries, paving the way for future therapeutic developments.

This research not only opens new avenues for the utilization of red seaweed but also underscores the importance of exploring marine resources for bioactive molecules. As the scientific community continues to delve into the vast potential of marine biotechnology, studies like this one bring us closer to harnessing the power of the ocean for the betterment of human health. The journey has just begun, and the possibilities are as vast as the sea itself.

Scroll to Top
×